Invokana (canagliflozin) tablets

Invokana (canagliflozin) is a prescription tablet in the SGLT2 inhibitor class for type 2 diabetes. This page summarizes dosing basics, safety, storage, and access factors that influence invokana price for cash-pay patients without insurance. Dispensing logistics may involve Ships from Canada to US, based on prescription requirements.

What Invokana Is and How It Works

Invokana contains canagliflozin, a sodium-glucose cotransporter 2 (SGLT2) inhibitor. This class lowers blood glucose by reducing glucose reabsorption in the kidneys, which increases glucose excretion in urine. Because the effect is tied to kidney filtration, kidney function is an important part of selection and follow-up. Some people also notice changes in urination and mild fluid loss, which can affect blood pressure.

Dispensing is handled by licensed Canadian pharmacies.

Beyond blood sugar control, the official indication set can include cardiovascular and kidney outcomes, depending on the approved labeling in a given country. For broader background on this medicine class, see SGLT2 Inhibitors and the overview article SGLT2 Inhibitor Drug Class. Care teams often review kidney labs before and during therapy. This is one reason the same prescription may not be appropriate for every person with diabetes.

Some orders may qualify for US delivery from Canada when documentation is complete and the product is eligible for cross-border referral fulfillment.

Who It’s For

Invokana is generally prescribed for adults with Type 2 Diabetes as part of an overall treatment plan that may include nutrition changes and other medicines. In U.S. labeling, it is indicated to improve glycemic control in adults with type 2 diabetes. The same labeling also includes risk-reduction indications for certain cardiovascular and kidney outcomes in specific patient groups. A prescriber determines whether those indications apply, based on history and lab results.

This medicine is not used for type 1 diabetes, and it is not a treatment for diabetic ketoacidosis (DKA). It may not be appropriate in people with severe kidney impairment, those on dialysis, or anyone with a serious hypersensitivity reaction to canagliflozin. People with frequent genital yeast infections, recurrent urinary infections, low blood pressure, or a history of foot ulcers may need additional screening and counseling before starting an SGLT2 inhibitor. Patient selection should follow the product monograph or prescribing information used by the dispensing pharmacy.

Why it matters: Kidney function affects both eligibility and how well SGLT2 inhibitors work.

Dosage and Usage

Invokana is taken by mouth once daily. In many product labels, dosing begins with 100 mg once daily, typically before the first meal of the day, and may be increased to 300 mg once daily in selected patients. Dose eligibility can depend on kidney function (for example, an estimated glomerular filtration rate, eGFR), as well as tolerability and concurrent therapies.

For anyone comparing access options, invokana price can vary by strength and the quantity supplied, so prescriptions should clearly state the intended dose and tablet strength. Patients using insulin or insulin secretagogues (such as sulfonylureas) may require closer monitoring for low blood sugar when an SGLT2 inhibitor is added. Clinicians may also give instructions for temporary interruption before surgery or during prolonged fasting to reduce DKA risk. These steps should be individualized and based on the official labeling.

• Administration timing: often before first meal
• Hydration: consider volume status
• Lab follow-up: kidney function checks
• Added therapies: monitor for hypoglycemia

Quick tip: Keep an updated medication list for travel or emergency visits.

Strengths and Forms

This medicine is supplied as an oral tablet. Common presentations include 100 mg and 300 mg strengths. In practice, prescribers select a strength based on treatment goals, kidney function, and the patient’s overall regimen. Availability can vary by pharmacy and by country-specific labeling, so the dispensed presentation should match the prescription exactly.

When comparing strengths, invokana price may differ between Invokana 100 mg tablets and invokana 300 mg tablets because the dose and package configurations can differ. The generic name is canagliflozin, which is useful when reviewing medication lists, lab orders, or interaction checks.

For additional non-insulin options often used alongside SGLT2 inhibitors, browsing the hub Non Insulin Medications can help frame what else may be in a regimen, without implying any switch or substitution.

Storage and Travel Basics

Store tablets at controlled room temperature, away from excess heat and moisture. Keep the bottle tightly closed and store it out of reach of children and pets. Do not transfer tablets into unmarked containers for long periods, since the original packaging helps preserve stability and reduces the risk of mix-ups.

For travel, keep tablets in carry-on luggage when flying, and bring a copy of the prescription or pharmacy label to support security checks and replacement needs. Avoid leaving medication in a parked car where temperatures can rise quickly. If a dose is missed, instructions in the patient information leaflet or product monograph should be followed; a clinician or pharmacist can clarify how to handle missed doses safely.

For education on diabetes management topics beyond a single product, the collection Type 2 Diabetes Articles can provide background on common therapy combinations and monitoring concepts.

Side Effects and Safety

Common side effects with SGLT2 inhibitors can include increased urination, thirst, genital yeast infections, and urinary tract infections. Some people may experience dizziness or lightheadedness, especially when starting therapy or when combined with diuretics. Because these effects relate to fluid and glucose in the urine, hydration status and personal infection history matter when evaluating tolerability.

Serious risks can include diabetic ketoacidosis (which can occur even if blood glucose is not extremely high), acute kidney injury, severe urinary infections, and rare but serious genital infections such as necrotizing fasciitis of the perineum (Fournier’s gangrene). Labeling for canagliflozin also includes cautions about lower-limb complications and fractures in some contexts. When reviewing benefit-risk tradeoffs, invokana price should never be the only consideration; the safety profile and monitoring plan matter.

When to seek urgent evaluation

Urgent evaluation is generally appropriate for symptoms that could signal DKA or severe infection. Concerning symptoms can include nausea, vomiting, abdominal pain, rapid breathing, confusion, unusual fatigue, fever, severe genital or perineal pain, or signs of dehydration such as fainting. Patients should follow their prescriber’s instructions for sick days, fasting, or surgery preparation. If severe symptoms occur, local emergency services or urgent care pathways should be used, rather than waiting for routine follow-up.

For a focused review of this class in cardiovascular settings, see Heart Failure Care Changes, which discusses class-wide considerations in plain language.

Drug Interactions and Cautions

Drug interactions with canagliflozin are often related to additive effects on blood sugar or fluid status. Combining an SGLT2 inhibitor with insulin or sulfonylureas can raise the risk of hypoglycemia, even though SGLT2 inhibitors alone have a lower hypoglycemia risk. Diuretics can increase the chance of low blood pressure and dehydration when used together with medicines that increase urination.

A valid prescription is required and may be verified.

Some medicines can change canagliflozin exposure through enzyme induction or inhibition, which may alter effectiveness or side effects. Digoxin levels may be affected in some cases, so monitoring may be considered. As a practical step, a complete medication list should include over-the-counter products and supplements. When people are comparing options, invokana price is only one variable; interaction risk and monitoring needs can change the overall suitability of therapy.

Kidney disease and heart failure histories may influence selection of an SGLT2 inhibitor versus another class. Background reading on kidney-related diabetes care is available in Chronic Kidney Disease and the article Dapagliflozin Kidney Health.

Compare With Alternatives

SGLT2 inhibitors are one of several non-insulin options used in type 2 diabetes. Within the same class, empagliflozin and dapagliflozin are common alternatives. Other classes used for glucose lowering include GLP-1 receptor agonists, DPP-4 inhibitors, metformin, and insulin, with selection based on comorbidities, kidney function, side-effect profiles, and patient-specific goals.

For class comparisons, the product pages for Jardiance Tablets and Farxiga Tablets provide basic presentation details, while comparative context is discussed in Invokana Vs Jardiance. Formulary status and dosing constraints can differ across products, which can affect day-to-day use. Even when two medicines are in the same class, monitoring plans and contraindications may not match.

When reviewing options with a clinician, a practical framework includes kidney function thresholds, history of recurrent infections, blood pressure status, and concurrent diuretic therapy. These factors often matter as much as invokana price when deciding which therapy is most appropriate for a given patient.

For a dosing-focused discussion of dapagliflozin as an alternative, see Farxiga Dosing Guide.

Pricing and Access: invokana price considerations

Costs for prescription diabetes medicines can vary widely based on strength, days’ supply, and whether the prescription is filled through an insurance benefit or a cash-pay pathway. Some patients compare the retail pharmacy amount with other fulfillment options, including referral-based cross-border access models, when permitted by documentation and dispensing rules. Coverage rules can also differ for Medicare Part D, commercial insurance, and employer plans, so the same medication may have different out-of-pocket amounts across patients.

Cash-pay access is available when insurance is not used.

Practical steps that may help reduce confusion when comparing costs include confirming the prescribed strength (100 mg vs 300 mg), ensuring the quantity matches the intended days’ supply, and checking whether prior authorization is required by an insurer. Site-wide updates may be listed on the Available Promotions page, where applicable. Browsing Diabetes Medications can also help patients understand what categories exist, without implying that alternatives are interchangeable.

Authoritative Sources

U.S. indications and safety details are summarized in the FDA application overview.

Patient-focused medication guidance is available from MedlinePlus canagliflozin.

To proceed with dispensing and delivery options, select prompt, express, cold-chain shipping during checkout if offered for the shipment type.

This content is for informational purposes only and is not a substitute for professional medical advice.